Skip to content

Transcutaneous Spinal Cord Stimulation for Parkinson Disease

Transcutaneous Spinal Cord Stimulation for Freezing of Gait in Parkinson Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04171076
Enrollment
5
Registered
2019-11-20
Start date
2019-10-15
Completion date
2019-11-30
Last updated
2019-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait, Rigid, Parkinson Disease

Brief summary

Spinal cord stimulation has been used to treat gait problems in Parkinson's disease, with positive results along some studies. The use of non-invasive stimulation can be an alternative to stimulate the spinal corn.

Detailed description

Spinal cord stimulation has been used to treat gait problems in Parkinson's disease, with positive results along some studies. The use of non-invasive stimulation can be an alternative to stimulate the spinal corn. In this pilot trial, the investigators recruit participants with Parkinson' disease and freezing of gait. The aim of the study is to explore the safety along the non-invasive magnetic thoracic spinal cord stimulation as well the effect on gait problems, especially freezing of gait, prospectively, in an open-label fashion.

Interventions

PROCEDURETranscutaneous spinal cord stimulation

Theta burst stimulation at thoracic level (T5) over 2 minutes

Sponsors

University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Pilot study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of advanced idiopathic Parkinson's disease * significant freezing of gait despite optimized treatment with medications and rehabilitation program

Exclusion criteria

* psychiatric symptoms * dementia * cardiac pacemaker

Design outcomes

Primary

MeasureTime frameDescription
Freezing of gait scoreOne weekThe primary outcome is the freezing of gait score. 12-item scale, each item scores 3 points at maximum; the score ranges from 0-36; higher scores mean higher severity

Secondary

MeasureTime frameDescription
Gait speedbaseline, 1 week, 4 weekGait speed measured through the time to up and go - It uses the time that a person takes to rise from a chair, walk ten meters, turn around, walk back to the chair, and sit down.
Freezing of gait questionnairebaseline, 1 week, 4 weekThe freezing of gait questionnaire assess the freezing of gait severity in 9-item scale ( ranging from 0-28 points); higher score mean higher severity
Safety of the intervention - urinary incontinence1 week, 4 weekIncidence of Patients self report problems: urinary incontinence. The urinary incontinence will be measure through the Revised Urinary Incontinence Scale, ranging from 0 to 16. Higher scores mean higher the urinary symptoms.
Safety of the intervention - lower limb strength.1 week, 4 weekIncidence of Patients self report problems: worsening in gait due to weakness. The lower limb strength will be measure through the neurologic exam. The force degree ranges from 0 - none, to 5 - normal strength.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026